AngioDynamics | ANGO - Sales Revenues


AngioDynamics reported $79.43M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 141.2M 700K Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
ICU Medical USD 525.77M 14.93M Mar/2026
Inogen USD 74.93M 504K Sep/2024
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Smiths GBP 1.44B 133M Jan/2026
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Trinity Biotech USD 14.31M 1.55M Sep/2025